Cardiac Implants LLC is a company headquartered in American Canyon, CA. The firm develops medical devices. Mark Turco is the current CEO of the firm.

The Japan Medical Device Development Organization aims to activate Japan's medical innovation and medical device industry, centering on the medical device incubation business, and aim for Japan to become a world leader in this field.Japanese Organization for Medical Device Development is a country of craftsmanship, possesses high technical and quality control skills, and should be good at producing medical equipment. However, in the medical device field, imports exceed 600 billion yen every year. Japan's “manufacturing” technology has not been fully utilized.

Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.

ValveXchange, Inc. develops two-part bioprosthetic tissue valves that resolve the compromises between conventional mechanical and tissue heart valves. It offers Vitality exchangeable heart valve systems; Vitality exchangeable tissue valves; valve delivery and exchange systems; transapical implants and exchanges; and apical introducers. ValveXchange is based in Aurora, Colorado.

InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy.

Jinshi Biotechnology (Changsu) Co., Ltd. (doing business as Kingstronbio) is a Chinese company located in Changsu specializing in surgical and medical instruments and apparatus. It was founded in 2012 by Sheng Ping Zhong, he has been the CEO since that date.

Shockwave Medical is developing the Lithoplasty™ family of balloon dilatation catheters that incorporate tiny lithotripsy electrodes designed to increase the compliance of rigid vascular and valvular lesions prior to low-pressure dilation, thereby limiting injury to healthy tissue and overcoming significant limitations of current revascularization technologies. The technology is built on traditional balloon catheter platforms rendering it inherently familiar and easy to use for cardiologists, interventional radiologists and vascular surgeons alike. In peripheral vessels, Lithoplasty™ could enable more effective angioplasty, less frequent bailout stent usage and enhanced lesion preparation prior to the use of drug eluting balloons (DEB) or bio-absorbable vascular scaffolds (BVS). In coronary vessels it could facilitate stent delivery and enhance vessel preparation prior to stent or BVS placement. Finally, in aortic valves the technology could vastly improve native tissue preparation prior to trans-catheter aortic valve replacement (TAVR) and valvuloplasty for those patients not suitable for TAVR.

Boston Scientific Ltd., part of Boston Scientific Corp., is a British company located in Hemel Hempstead. The firm distributes medical products. It was founded in 1992.\nThe company says this about itself: Boston Scientific Ltd designed, manufactured and sold transvaginal mesh (“TVM”) medical devices that were implanted into thousands of Canadian women for the treatment of Stress Urinary Incontinence (“SUI”) and Pelvic Organ Prolapse (“POP”).

Shanghai Hanling Medical Equipment Co., Ltd., established on 2019-02-15, Business scope includes licensed projects:Production of Class III Medical Devices;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Sales of Class I Medical Devices,Sales of Class II Medical Devices,Rubber Products Sales,Sales of plastic products,Research and development of bio-based materials technology,Sales of bio-based materials,Research and development of bio-based material polymerization technology,engaged in medical equipment(In addition to three categories)Technology development in the field of expertise,Technical Services,technology transfer,technical consulting.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Chengdu Sailanuo Medtech Co., Ltd. engages in the research, development, manufacture, and sales of medical devices. The company was founded on April 6, 2017 and is headquartered in Chengdu, China.

Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China.

CryoLife, is a biological medical device company, which has been focused on the development of implantable biological devices, surgical adhesives, and biomaterials for use in cardiac and vascular reconstruction for patients for all ages. The Company preserves and distributes human tissues and develops, manufactures, and commercializes medical devices for cardiac and vascular transplant applications. The human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve (CryoValve SGPV) and the CryoPatch SG pulmonary cardiac patch tissue (CryoPatch SG), both processed using its SynerGraft technology. CryoLife's medical devices consist primarily of surgical adhesives, sealants, and hemostats, including BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam), PerClot and HemoStase. In October of 2010, the Company began distributing PerClot for Starch Medical, Inc. (SMI). In May 2011, it acquired Cardiogenesis Corporation.

Rex Medical specializes in the development, manufacturing, and marketing of innovative, minimally invasive medical devices targeted toward the cardiovascular, venous access, endosurgery, and oncology markets to address unmet clinical needs. Medical device companies play a vital role in the life science industry by developing new technologies to match unmet medical needs across both established and emerging healthcare markets.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&D, manufacturing, marketing, and technical consulting services. We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost importance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.